I'd say that most stocks are hard to judge on TA alone, but I think this dynamic is magnified with spec stocks.
By its very nature this spec stock is a speculation on a successful outcome of management's current prospective (fundamental) activities - whether it's developing a new sensor tech or drilling for minerals, etc... Significant discoveries/break-throughs can result in a sudden and siesmic re-rating of a stock - particularly for a young company like PSY - which can turf TA on its head for a while.
The idea behind TA, in all its varying forms, is the implied promise of being able to identify market opportunities through a somewhat structured behavioural model (ie. manifested as recognisable price patterns) that a market for a stock/commodity might adhere to, which we try to exploit to our advantage. I say 'implied promise' because there are times in which TA works beautifully and other times when it just doesn't.
Personally, I favour a combo of TA and FA. But with spec stocks there's an important third element that is probably more important to be mindful of; speculation that a company-making outcome/event/discovery will materialise and justify the risk capital that we have laid down.
chart, page-14
- There are more pages in this discussion • 828 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HYD (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.067M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 211500 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 400000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 111500 | 0.015 |
2 | 766733 | 0.014 |
1 | 40000 | 0.013 |
1 | 166666 | 0.012 |
2 | 789356 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 400000 | 1 |
0.020 | 203968 | 2 |
0.022 | 205000 | 2 |
0.026 | 17679 | 1 |
0.027 | 203615 | 1 |
Last trade - 16.12pm 06/05/2024 (20 minute delay) ? |
Featured News
HYD (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online